Download PDF
CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2013; 34(04): 336-337
DOI: 10.4103/0971-5851.125267
LETTERS TO EDITOR

Heparin-induced thrombocytopenia in a patient with colon cancer

Ajaz Nabi Koul
Department of Internal Medicine, SKIMS, Srinagar, Jammu and Kashmir, India
,
Ridwana Ahad
Department of Community Medicine, SKIMS, Srinagar, Jammu and Kashmir, India
› Author Affiliations
› Further Information
  PDF Download Permissions and Reprints


Publication History

Article published online:
19 July 2021

© 2013. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Chong BH, Castaldi PA. Platelet proaggregating effect of heparin: Possible mechanism for non-immune heparin-associated thrombocytopenia. Aust N Z J Med 1986;16:715-6.
  • 2 Greinacher A. Antigen generation in heparin-associated thrombocytopenia: The nonimmunologic type and the immunologic type are closely linked in their pathogenesis. Semin Thromb Hemost 1995;21:106-16.
  • 3 Warkentin TE, Greinacher A, Koster A, Lincoff AM, American College of Chest Physicians. Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8 th Edition). Chest 2008;133:340S-8.
  • 4 Stanton PE Jr, Evans JR, Lefemine AA, Vo NM, Rannick GA, Morgan CV Jr, et al. White clot syndrome. South Med J 1988;81:616-20.
  • 5 Martel N, Lee J, Wells PS. Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: A meta-analysis. Blood 2005;106:2710-5.
  • 6 Mercier C, Ciccolini J. Severe or lethal toxicities upon capecitabine intake: Is DPYD genetic polymorphism the ideal culprit? Trends Pharmacol Sci 2007;28:597-8.